Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Pancreatic Cancer Research Team
Sponsor:
Information provided by (Responsible Party):
Pancreatic Cancer Research Team
ClinicalTrials.gov Identifier:
NCT01488552
First received: November 18, 2011
Last updated: April 3, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)